924
Participants
Start Date
October 27, 2021
Primary Completion Date
October 24, 2023
Study Completion Date
October 24, 2023
Dymista
1 spray per nostril twice daily up to four weeks
Pantai Hospital Ipoh, Perai
Hong Kong ENT Clinic, Hong Kong
Asia Priority Healthcare, Kowloon
Kempas Medical Center, Johor Bahru
KPJ Johor Specialist Hospital, Johor Bahru
Allergy and Immunology Clinic Gleneagles Kuala Lumpur, Kuala Lumpur
University Malaya Medical Centre, Kuala Lumpur
Hospital Universiti Sains Malaysia, Kubang Kerian
Sarawak General Hospital, Kuching
Hospital Sultan Abdul Aziz Shah, Serdang
St. Martin De Porres Hospital, Chiayi City
Chang Gung Memorial Hospital-KAOHSIUNG, Kaohsiung City
Asia University Hospital, Taichung
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
National Taiwan University Hospital, Taipei
Taipei Medical University Hospital, Taipei
Taipei Municipal Wan Fang Hospital, Taipei
China Medical University Hsinchu Hospital, Zhubei
Bangkok hospital, Bangkok
King Chulalongkorn Memorial Hospital (Department of Medicine), Bangkok
King Chulalongkorn Memorial Hospital (Department of Pediatrics), Bangkok
King Chulalongkorn Memorial Hospital, Bangkok
Phramongkutklao Hospital, Bangkok
Rajavithi Hospital, Bangkok
Ramathibodi hospital, Bangkok
Siriraj Hospital (Department of Medicine), Bangkok
Siriraj Hospital (Department of Otorhinolaryngology), Bangkok
Thammasat University Hospital (Department of Otolaryngology), Bangkok
Thammasat University Hospital (Department of Pediatrics), Bangkok
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai
Naresuan University Hospital, Phitsanulok
Songkla University Hospital, Songkhla
Lead Sponsor
MEDA Pharma GmbH & Co. KG
INDUSTRY
Mylan Inc.
INDUSTRY